
Ontario doctors don't get paid when they treat uninsured patients. Here's how that might change
That's because the man doesn't have a valid health card — and he's not the only one.
Ho said many doctors are forced to bear the cost of caring for people in need who can't prove they have health insurance.
"We see them all the time. And unfortunately, we're not paid for them," Ho told CBC Toronto.
Currently, most doctors across the province can't invoice the Ontario Health Insurance Plan (OHIP) for patients who can't prove they have coverage.
The Ontario Medical Association is hoping to change that and is working to finalize a new compensation deal with the provincial government that includes the reintroduction of what it calls a "good-faith" payment policy, first scrapped in 1998.
What is a 'good-faith' payment policy?
During the COVID-19 pandemic, Ontario revived a version of 20th-century "good-faith" payment policy, creating a stream of funding to ensure doctors got paid whenever they treated someone, even when the patient was not insured. The policy was scrapped again in 2023.
The Ministry of Health told CBC Toronto in a statement it's unable to comment on specific proposals while in active bargaining with the OMA.
If the proposal is approved, the "good-faith" payment system would kick in under three scenarios, according to the OMA:
Newborn patients experiencing glitches or delays while they await a permanent health card.
People who are OHIP-eligible but don't have valid documentation or valid coverage, a category which could include people experiencing homelessness, mental health issues or other barriers to documentation.
Uninsured patients presenting in critical conditions, who are unable or don't have someone available to provide documentation. The category could include undocumented residents, temporary residents experiencing lapses in coverage, uninsured travelers facing medical emergencies, and individuals facing complications or emergencies after elective health or birth tourism.
'Free for all' not the goal, OMA president says
It's that third scenario, in which doctors would bill for care for uninsured patients, that could face pushback, the OMA noted in a 2024 report.
"The Ministry may indicate that this is simply not their problem to manage … Some members of the public may feel similarly," the report says.
Under the proposed policy, hospitals would need to make reasonable attempts to verify someone's coverage, said OMA president Dr. Zainab Abdurrahman.
But if that's not possible, she believes the doctors caring for them should still get paid.
"Our real focus is really the OHIP-eligible. Could someone [ineligible] slip in there? There's always a possibility," Abdurrahman said.
"We're being very specific and very intentional … to help allay the fears that this is just going to be a free-for-all for everyone to come and get Ontario taxpayer-paid health care," she said. "That's not our goal."
When the policy was in place during the pandemic, the OMA found that 7,000 Ontario physicians provided 400,000 instances of care to patients without insurance.
Similar programs exist across Canada: OMA
It's unclear whether bringing back the policy could incentivize more medical tourism, said Boriana Miloucheva, an assistant professor of health economics at the Dalla Lana School of Public Health.
"The option to get medical services and not pay [the bill] already exists," she said. "It's a good-faith program, but there should be reviews about who is actually billing and what they're actually billing," she said.
Other provinces, such as B.C., Alberta, Saskatchewan, and Quebec, do provide similar payment options for emergencies, according to the OMA. Some of them allow retroactive billing or accept mailing addresses from homeless shelters as proof of residency for those without a health card.
A similar policy was also recently implemented in Manitoba.
Ontario doctors are close to a new compensation deal. Here's what it includes
7 days ago
The Ontario Medical Association is hoping to strike a new deal with the province that would change the way family physicians are compensated. CBC's Dale Manucdoc has more on what the proposed deal includes.
Ultimately, says Dr. Ho, this is about more than getting compensated for work. He says it's a health equity issue for the province's most vulnerable populations, who might delay care or turn down prescriptions they can't pay for because they can't prove they're eligible for OHIP.
Ho says the policy could end up saving the province money, since people postponing care could face more serious health issues that need treating later on.
"We do need to reduce these barriers to care and … create fair processes for these patients because they are disproportionately affected by this," he said.
Abdurrahman said she's hoping for an update on the proposed policy this fall.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


National Post
9 minutes ago
- National Post
Man asks ChatGPT for advice on how to cut salt, ends up in hospital with hallucinations
Article content The man already followed a very restrictive diet, one that doctors found was impacting his levels of important micronutrients, like vitamin C and B12. He was also reportedly very thirsty, but at the same time very worried about the quality of the water he was being offered, since he distilled his own water. He was thoroughly tested and first kept at the hospital for electrolyte monitoring and repletion. Article content His test results, combined with the hallucinations, and other reported symptoms, including new facial acne, fatigue and insomnia, led the medical staff to believe the patient had bromism. Article content Bromism, a condition that was mostly reported in the early 20th century, is caused by ingesting high quantities of sodium bromide. The normal levels of bromide are between 0.9 to 7.3 mg/L, but this patient had 1,700 mg/L. Article content The patient remained in the hospital for treatment for three weeks, and was stable at his check-up two weeks after his discharge. Article content Bromism cases decreased after the U.S. Food and Drug Administration (FDA) eliminated the use of bromide in the 1980s, the authors wrote. It was previously used in treatments for insomnia, hysteria and anxiety. However, the disease has reemerged now, with bromide being added to some unregulated dietary supplements and sedatives and the consumption of excess dextromethorphan, a substance included in cough medicine. Article content Article content 'While cases of bromism may remain relatively rare, it remains prudent to highlight bromism as a reversible cause of new-onset psychiatric, neurologic, and dermatologic symptoms, as bromide-containing substances have become more readily available with widespread use of the internet,' the authors wrote. Article content The doctors said that AI tools can be great for creating a bridge between scientists and the general population, but it also carries a risk of producing misinformation and giving information out of context, something that doctors are trained not to do. Article content 'As the use of AI tools increases, providers will need to consider this when screening for where their patients are consuming health information,' the authors said in the case study. Article content OpenAI, the company that created ChatGPT, recently announced changes to their system, including being more careful when it comes to health-related questions. In one of the examples, the chatbot gives information but also includes a note about checking in with a health professional. Article content 'Our terms say that ChatGPT is not intended for use in the treatment of any health condition, and is not a substitute for professional advice. We have safety teams working on reducing risks and have trained our AI systems to encourage people to seek professional guidance,' OpenAI said in a statement. Article content

Globe and Mail
an hour ago
- Globe and Mail
Eli Lilly hikes price of Mounjaro weight-loss drug in Canada, Britain after pressure from Trump
U.S. drugmaker Eli Lilly & Co. has increased prices of its popular diabetes and anti-obesity drugs in Canada as it responds to pressure from the Trump administration to lower prices in the United States and raise them elsewhere. The company also announced it is sharply raising prices in Britain to match those in other European markets. The moves make the company one of the most high-profile so far to respond U.S. President Donald Trump's direction to rebalance global drug prices. 'Lilly supports the administration's goal of keeping the United States the world's leading destination for biopharmaceutical research and manufacturing, and the objective of more fairly sharing the costs of breakthrough medical research across developed countries,' the company said Thursday in an unsigned statement. 'This rebalancing may be difficult, but it means the prices for medicines paid by governments and health systems need to increase in other developed markets like Europe in order to make them lower in the U.S.' Is working out necessary in the age of Ozempic? Lilly is raising the list price in Britain for Mounjaro, its type 2 diabetes treatment, by 170 per cent, Reuters reported. The market for weight-loss drugs has exploded in recent years, led by Novo Nordisk's Ozempic and Wegovy, which are prescribed for diabetes and obesity, respectively. Ozempic earned $2.5-billion at retail pharmacies in Canada in 2024, according to data from industry broker IQVIA, nearly triple the next best-selling drug. Lilly introduced Mounjaro in Canada in late 2023. It was originally sold in single-dose vials (taken weekly) at a wholesale price of around $80. It is sold in six different dosages. The company then introduced a four-dose format called Kwikpen in January of 2025 and then a Kwikpen form of Zepbound, for obesity, in June. At the same time, it raised the prices of the single-dose vials to be in line with those of the Kwikpen and lowered production of the vials, leading to low inventories across the country. Cubic Health, a company that analyzes drug prices for insurance plan sponsors, said in a recent note to its clients that the annual cost of taking Mounjaro has more than doubled for high dosages since it first came to Canada. Cubic said the wholesale price for the Kwikpen now ranges from $387 to $773 depending on dosage, which can lead to an annual cost of more than $10,000. (Individual costs can vary depending on pharmacy, insurance coverage, discounts and other factors.) 'Vials were only intended as a short-term solution until a multidose pen became available to the Canadian market,' Lilly spokesman Ethan Pigott said in a statement. 'Lilly will continue to support patients already using the vial format, but the KwikPen device will be prioritized go-forward for its supply sustainability, ease of use and multidose presentation.' He also said discussion of price should include multiple factors. 'Both Mounjaro and Zepbound are priced to reflect the value they can provide to individuals, health systems, and society in treating type 2 diabetes and obesity,' Mr. Pigott said. Mounjaro and Zepbound are covered by some private insurance plans, depending on individual plan designs. The drugs are not yet covered by any public insurance plans, which require going through national bodies that assess drugs and negotiate prices. Lilly had started an application to Canada's Drug Agency to have Mounjaro (also known as tirzepatide) assessed in 2022, but a spokesperson for the CDA said the submission was cancelled because of paperwork deficiencies. Earlier: Generic version of Ozempic, Wegovy to launch in Canada by Hims & Hers Mr. Pigott said Lilly is finalizing plans to resubmit Mounjaro, along with Zepbound, to the CDA 'in 2025.' While the average cost of these drugs in Canada is up, it is still a little short of prices in the U.S. The wholesale price of Zepbound in the U.S. is US$1,086, according to Lilly's website. It also offers direct-to-consumer sales in the U.S. at prices that range from US$349 to US$1,049, depending on dosage. Lilly has not yet launched direct sales in Canada. Drug prices in the U.S. are, on average, more than three times those in Canada. Mr. Trump has repeatedly mentioned that statistic as he admonishes drug companies for their prices. In May, he signed an executive order that directed Health Secretary Robert F. Kennedy Jr. to work with drug companies on 'most favoured nation' pricing for pharmaceuticals. Trump says new order will lower U.S. drug prices and increase them everywhere else Two weeks ago, Mr. Trump sent letters to 17 drug companies – including Lilly – telling them to increase prices in non-U.S. markets to make up for lower revenue in the U.S. The administration has also launched a national-security investigation of the sector that could lead to tariffs, which Mr. Trump has mused could be as high as 200 per cent. In Lilly's statement on Thursday, the company said it does not support tariffs. 'Broad tariffs would raise costs, limit patient access and undermine American leadership, especially for companies already investing heavily in domestic manufacturing,' the company said.


CTV News
an hour ago
- CTV News
Dairy Queen Blizzards help raise funds for CHEO on Miracle Treat Day
For 13-year-old Lu Oudhoff, a Dairy Queen Blizzard comes with a serving of hope. 'It's really great that we get to help them by eating ice cream, because ice cream is awesome,' said Lu. Lu knows firsthand what CHEO can do for young people. 'I had a depressive episode, and I was suffering anxiety. CHEO sort of helped me through it and made it so that I wasn't feeling so alone.' It's a feeling echoed by Lu's mom, Rose Spangers. 'For Lu to have been able to turn something that was really a very tough period for them into something that empowers them and helps them give something back to the hospital that has been such an amazing support for them throughout their mental health journey, that's been amazing,' Spangers said. This year marks 41 years of partnership between Dairy Queen and the Children's Miracle Network, with more than $55 million raised for Canadian hospitals since 1984. Miracle Treat Day Ottawa Dairy Queen stores are supporting CHEO on Miracle Treat Day. Aug. 14, 2025. 'Every year, Miracle Treat Day is held across the country as part of Children's Miracle Network and Dairy Queen locations are kind enough to donate their net proceeds from Blizzard sales to the local children's hospital,' said Steve Read, CHEO Foundation president and CEO. Supporting CHEO is something many in the community are proud to do. 'We work in construction, and we do this every year for the guys,' said DQ customer Donalda Tryon, who ordered 15 Blizzards for her crew. 'We do it at Camp Tay for Tim Hortons. We do it on McDonald's day as well, so it just helps out everyone.' Miracle Treat Day Proceeds from Dairy Queen Blizzards on Miracle Treat Day are donated to children's hospitals in Canada. (Dave Charbonneau/CTV News Ottawa) 'I think CHEO, in our community, to have that level of care for kids, we're so fortunate to have so close by,' said DQ customer Rebecca Laginski. This year, more than 660 Dairy Queen stores are supporting 13 children's hospital foundations across the country. 'This helps us give back to the community in the best way possible. To raise funds for the children, the future of our country. And raise money for all the Children's Miracle Network hospitals,' said Noman Hussain, Dairy Queen Eastern Ontario business consultant. Miracle Treat Day Supporting CHEO on Miracle Treat Day is as easy as buying a Dairy Queen Blizzard. (Dave Charbonneau/CTV News Ottawa) As for Lu, making a difference has never been so sweet. 'We literally just buy an ice cream and then bam, we're helping CHEO.'